Equity

Total Liabilities & Equity

Pfizer Total Liabilities & Equity decreased by 0.3% to $207.62B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 0.2%, from $208.03B to $207.62B. Over 5 years (FY 2020 to FY 2025), Total Liabilities & Equity shows an upward trend with a 6.2% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementBalance Sheet Statement
SectionEquity
CategoryOther
SignalHigher is better
VolatilityStable
First reportedQ4 2014
Last reportedQ1 2026May 5, 2026

How to read this metric

Growth in this figure generally indicates an expansion of the company's asset base and operational scale.

Detailed definition

This is the sum of all financial obligations and shareholder equity, which must mathematically equal total assets. It re...

Peer comparison

Standard balance sheet total; used as a denominator for various leverage and efficiency ratios across all industries.

Metric ID: total_liabilities_and_equity

Historical Data

20 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$169.92B$179.19B$181.48B$183.84B$195.29B$195.35B$197.21B$195.62B$220.17B$215.02B$226.50B$221.10B$216.19B$219.48B$213.40B$208.03B$206.10B$208.73B$208.16B$207.62B
QoQ Change+5.5%+1.3%+1.3%+6.2%+0.0%+0.9%-0.8%+12.6%-2.3%+5.3%-2.4%-2.2%+1.5%-2.8%-2.5%-0.9%+1.3%-0.3%-0.3%
YoY Change+14.9%+9.0%+8.7%+6.4%+12.7%+10.1%+14.9%+13.0%-1.8%+2.1%-5.8%-5.9%-4.7%-4.9%-2.5%-0.2%
Range$169.92B$226.50B
CAGR+4.3%
Avg YoY Growth+4.1%
Median YoY Growth+4.2%
Current Streak2 quarters decline

Frequently Asked Questions

What is Pfizer's total liabilities & equity?
Pfizer (PFE) reported total liabilities & equity of $207.62B in Q1 2026.
How has Pfizer's total liabilities & equity changed year-over-year?
Pfizer's total liabilities & equity decreased by 0.2% year-over-year, from $208.03B to $207.62B.
What is the long-term trend for Pfizer's total liabilities & equity?
Over 5 years (2020 to 2025), Pfizer's total liabilities & equity has grown at a 6.2% compound annual growth rate (CAGR), from $154.23B to $208.16B.
What does total liabilities & equity mean?
The total amount of funding the company has received from both creditors and shareholders.